Free News Archives
Latest Issue of OR Manager
May 2025

Infusion pumps deemed high-risk in FDA early alert

Editor's Note Baxter Healthcare Corporation has issued a letter to affected customers recommending certain Spectrum infusion pumps be removed from where they are used or sold, according to a March 5 early alert from the US Food and Drug Administration (FDA). The FDA notice concerns the Sigma Spectrum Infusion System…

Read More

By: Matt Danford
March 5, 2025
Share

Stem cell researchers tout potential for sickle cell disease cure

Editor's Note A novel stem cell transplant treatment for sickle cell disease (SCD) led to disease-free outcomes for most participants in a clinical trial at a lower cost than gene therapy, according to a February 27 report in Sickle Cell Disease News. The approach, which relies on a less intensive…

Read More

By: Matt Danford
March 5, 2025
Share

Study: Stem cell therapy restores vision in LSCD patients

Editor's Note A novel stem cell treatment for unilateral limbal stem cell deficiency (LSCD)—a type of corneal disease caused by injury—restored corneal function in half of study participants within three months, according to a March 5 report in Medical News Today. According to the article, the experimental therapy, cultivated autologous…

Read More

By: Matt Danford
March 5, 2025
Share

AMSURG launches nationwide campaign to spotlight rising colon cancer rates, urges early screening

Editor's Note Coinciding with Colon Cancer Awareness Month, AMSURG—a leading provider of ambulatory surgery center (ASC) services and GI care—has launched an educational push to boost colonoscopies and reduce soaring colon cancer rates, particularly among younger adults, a March 3 press release reports. The campaign highlights the lifesaving impact of…

Read More

By: Tarsilla Moura
March 5, 2025
Share

AAAHC seeks stakeholder feedback on revised v44 standards to elevate patient-centered care

Editor's Note The Accreditation Association for Ambulatory Health Care (AAAHC) has opened a public comment period for proposed revisions to its v44 standards, ASC Focus February 28 reports. From now until March 29, healthcare professionals and other stakeholders are encouraged to share insights that will help refine the guidance for…

Read More

By: Tarsilla Moura
March 5, 2025
Share

Hospital’s anesthesia reforms slash carbon footprint, expenses

Editor's Note Universitätsmedizin Berlin reduced anesthesia-related carbon emissions by more than 80% since 2018 by eliminating high-impact anesthetic gases, implementing education initiatives, and revising clinical guidelines, according to a February 27 report in Medical Xpress. The hospital’s efforts targeted desflurane, an anesthetic gas with an extreme climate impact—nearly 8,000 times…

Read More

By: Matt Danford
March 4, 2025
Share

Study: Shifting imaging to outpatient centers could save billions

Editor's Note Moving radiology services from hospitals to outpatient centers could slash healthcare costs by billions annually while improving patient care, according to a March 3 Radiology Business News report on a study published in the American Journal of Roentgenology (AJR). The study found that shifting just 10% of hospital-based…

Read More

By: Matt Danford
March 4, 2025
Share

Report: Health system margins shrink as hospital revenue grows

Editor's Note Operating margins for health systems declined across the US in early 2025 even as hospitals reported steady revenue growth, according to a February 27 report from Strata Decision Technology. The median operating margin for U.S. health systems dropped to 1.0% in January, down from 2.1% in December, marking…

Read More

By: Matt Danford
March 4, 2025
Share

Study: Cataract surgery increases diabetic retinopathy progression

Editor's Note Cataract surgery raises the risk of worsening diabetic retinopathy in adults with type 2 diabetes, according to a February 24 article in MedPage Today. The article focused on a a retrospective analysis published in the journal Ophthalmology. The study involved a large dataset from the TriNetX research network,…

Read More

By: Matt Danford
March 3, 2025
Share

FDA announces Class 1 endovascular system, anesthesia system recalls

Editor's Note The US Food and Drug Administration (FDA) designated Getinge’s recall of Vaporizer Sevoflurane Maquet Filling and Sevoflurane Quick-Fil and Philips’ recall of Tack Endovascular Systems as Class 1s, the most severe category indicating serious risk of injury or death. The Getinge recall is an expansion of a 2024…

Read More

By: Matt Danford
March 3, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat